Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$40,702,881
-$979,763 QoQ
Shares Held
214,655
+1.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#172
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCOTIA CAPITAL INC. holds $612,343,239 across 12 Drug Manufacturers - General names. AZN ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,197,406 | $304,105,201 | |
| 2 | LLY |
ELI LILLY & Co
|
92,763 | $111,262,734 | |
| 3 | ABBV |
AbbVie Inc.
|
187,501 | $47,182,751 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
214,655 | $40,702,881 | |
| 5 | MRK |
Merck & Co., Inc.
|
185,895 | $23,887,507 | |
| 6 | PFE |
Pfizer Inc
|
808,429 | $19,466,970 | |
| 7 | NVO |
Novo Nordisk A S
|
390,351 | $18,713,426 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,501 | $16,108,476 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,702,881 | 214,655 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $41,682,644 | 211,351 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||